Company
United StatesPublic company, NASDAQ: COGTCogent Biosciences, Inc. (NASDAQ: COGT), Waltham, MA – FDA Inspections
Inspection records and compliance data for Cogent Biosciences, Inc. in Waltham, MA. 1 FDA inspection on record, last inspected April 24, 2026. Publicly traded as NASDAQ: COGT.
Company Profile
This profile covers Cogent Biosciences, Inc. based in Waltham, MA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected April 24, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 24, 2026 | Not classified | Human Drugs | 1316132 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cogent Biosciences, Inc.
Stock ticker
COGT
Exchange
NASDAQ
Share price
$29.14
Market cap
$5.1B
Price as of
November 13, 2026
FEI Number
3026919714
Address
275 Wyman St Fl 3, Waltham, MA 02451-1200, United States
Country
United States
ID: abfa9948-d1ad-48cc-b569-80b10b922622